インフォメーション

Table of Contents How Is Eligibility for Vyznova Determined? Examinations to Prepare for Your Remote Consultation Clinical History and Basic Information Anterior Segment Imaging (Corneal Examinations) Posterior Segment Imaging (Retina and Optic Nerve Examinations) Who Is a Good Candidate for Vyznova? To determine whether Vyznova (neltependocel) treatment may be right for you, we need to carefully evaluate the current condition of your eye. Not every patient with bullous ker

If your vision has been slowly clouding and you have been told that a corneal transplant may be your only option, you are not alone, and you may have more choices than you realize. Access Vyznova (neltependocel) exclusively at Japan's leading specialized corneal centers. As your trusted gateway, we provide precise information to help you select a medical institution and corneal specialist well-suited to your unique needs, calmly and without pressure. From arranging direct onl

"Ophthoagent" is a service that connects patients worldwide with Japanese ophthalmologists, offering expert information and consultation grounded in my insight as a practicing ophthalmologist. “Freeing patients from the burden of choice when seeking a specialist.” “Smoothly reaching the specialist who is best suited for you.” At Vision Forth Inc., our goal is to provide patients with a future defined by these two ideals. We want to eliminate the uncertainty for those who worr

<Profile> Shigeto Shimmura, MD, PhD Professor and Chair, Department of Clinical Regenerative Medicine, Fujita Health University Spent his youth in Montreal, Canada, before entering the Keio University School of Medicine in 1983. Since graduating in 1989, he has specialized in ophthalmology and regenerative medicine. As a leading cornea specialist, Dr. Shimmura has performed over 1,000 corneal transplants and more than 100 corneal regenerative medicine surgeries. He has also c

1.Introduction Japan has established itself as a global leader for advanced ophthalmic regenerative medicine, offering new possibilities for restoring vision previously considered untreatable. As patients worldwide seek reliable medical solutions, ophthalmic care in Japan has progressed from slowing disease progression to actively regenerating visual function. Supported by a strict yet proactive regulatory framework for regenerative therapeutics, Japan has achieved multiple w

1.Introduction: The Standard of Visual Precision For global executives and individuals who prioritize Quality of Life (QOL), the criteria for choosing ophthalmic care have shifted. It is no longer just about treating a disease, but about securing a high quality of post-operative vision—specifically, the restoration of precise contrast and achieving the target refraction. In 2026, Japan is increasingly recognized as an attractive destination for medical tourism, due in part to

If you or a family member is scheduled for Vyznova corneal endothelial cell injection therapy, knowing what happens on surgery day — from the moment you arrive to the critical three-hour face-down positioning period — can transform anxiety into confidence. This guide provides a comprehensive, clinically grounded walkthrough of the entire procedure, explains the rationale behind prone positioning, and answers the questions patients ask most. By the end, you will understand not

International patients seeking Vyznova corneal endothelial cell therapy in Japan need a clear roadmap. This guide provides step-by-step instructions for finding candidate hospitals, securing medical visas, budgeting total costs, and planning your treatment itinerary from initial consultation to post-operative follow-up. Table of Contents Why Japan for Vyznova Corneal Regenerative Treatment? Finding Vyznova Partner Hospitals in Japan Understanding Medical Visa Requirements for

1. Why Japan is the Global Gold Standard for Eye Care Ophthalmology is a field of modern medicine that demands an extraordinary level of delicacy and precision. In the pursuit of preserving visual function, Japan has established a global reputation for excellence through consistent clinical standards and superior technical expertise. The high success rate of treatment in Japan is driven by a unique synergy: the fusion of refined surgical skill and advanced medical technology.

Table of Contents What is Bullous Keratopathy? Disease Burden and Treatment Limitations What is Vyznova (Neltependocel)? Mechanism of Action and Product Overview Japanese Clinical Data Facilitating PMDA Approval Experience to Date: Post-Launch Real-World Outcomes Cell Therapy vs Standard Corneal Transplant: Clinical Advantages of Vyznova Regulatory Status and Global Development Outlook Industry and Market Impact Conclusion: A New Paradigm in Corneal Endothelial Disease Manage